Publication Beamlines Strategic Pillar
マーク・アンダーソン; Anderson Mark; ジエイー・ワン; Jieyi Wang; アルチャナー・タークル et al. (2020). Prolactin receptor binding proteins and their use. Patent Number: JP2020188775A.
Дуглас УЛРИХ (2022). Output window for electron beam in isotope production. Patent Number: RU2762668C9.
Mark Anderson; Jieyi Wang; Archana Thakur; Debra Chao; Chung-Ming Hsieh et al. (2021). Prolactin receptor binding proteins and uses thereof. Patent Number: US20210312797A9.
Douglas ULLRICH (2022). Exit window for electron beam in isotope production. Patent Number: US11476076B2.
Douglas ULLRICH (2022). Exit window for electron beam in isotope production. Patent Number: AU2018212953B2.
Xueliang Sun; Xiaona LI; Jianwen LIANG; Changhong Wang; Huan Huang et al. (2022). Solid electrolyte material for lithium secondary battery, electrode, and battery. Patent Number: US20220216507A1.
道格拉斯·乌尔里希 (2022). Electron beam exit window in isotope production. Patent Number: CN110402614B.
Charles W Hutchins; Mark Anderson; Jieyi Wang; Archana Thakur; Debra Chao et al. (2020). Prolactin receptor binding proteins and uses thereof. Patent Number: ZA201504803B.
孙学良; 李晓娜; 梁剑文; 王长虹; 黄欢 et al. (2020). Solid electrolyte material for lithium secondary battery, electrode, and battery. Patent Number: WO2020220697A1.
ウルリッヒ，ダグラス (2022). Electron beam exit window in isotope production. Patent Number: JP7162598B2.
Xueliang Sun; Xiaona Li; Jianwen LIANG; Changhong Wang; Huan Huang et al. (2022). SOLID ELECTROLYTE MATERIAL FOR LITHIUM SECONDARY BATTERY, ELECTRODE AND BATTERY. Patent Number: EP3965199A4.
孙学良; 王长虹; 梁剑文; 李晓娜; 黄欢 et al. (2021). Electrode, electrolyte thin layer and preparation method thereof. Patent Number: CN112467074A.
孙学良; 李晓娜; 梁剑文; 黄欢; 卢世刚 et al. (2021). Solid electrolyte material and all-solid-state battery. Patent Number: CN112467196A.
Yang Shao-Horn; Yuriy ROMAN; Jiayu PENG (2022). Transition metal nitrides as solid carriers for ammonia storage. Patent Number: WO2022035961A1.
Anish SURI; Steven Sheriff; Suzanne Suchard; Aaron YAMNIUK; Stanley Krystek et al. (2021). Methods of treating immune diseases by administering antibody polypeptides that antagonize CD40. Patent Number: US11136406B2.